OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
Tesfaye Gelanew, Andargachew Mulu, Markos Abebe, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 859-859
Open Access | Times Cited: 13
Tesfaye Gelanew, Andargachew Mulu, Markos Abebe, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 859-859
Open Access | Times Cited: 13
Showing 13 citing articles:
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 276
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 276
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
Shabir A. Madhi, Gaurav Kwatra, Simone I. Richardson, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 3, pp. 295-306
Open Access | Times Cited: 22
Shabir A. Madhi, Gaurav Kwatra, Simone I. Richardson, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 3, pp. 295-306
Open Access | Times Cited: 22
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic
Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 22
Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 22
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 180-180
Open Access | Times Cited: 3
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 180-180
Open Access | Times Cited: 3
The current status of COVID-19 vaccines. A scoping review
Manuel Rueda-Fernández, Lucia Melguizo‐Rodríguez, Víctor J. Costela‐Ruiz, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103336-103336
Open Access | Times Cited: 15
Manuel Rueda-Fernández, Lucia Melguizo‐Rodríguez, Víctor J. Costela‐Ruiz, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103336-103336
Open Access | Times Cited: 15
Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines
Melissa García‐Vega, Hui Wan, Mónica Reséndiz‐Sandoval, et al.
Genes and Immunity (2024) Vol. 25, Iss. 2, pp. 158-167
Closed Access | Times Cited: 2
Melissa García‐Vega, Hui Wan, Mónica Reséndiz‐Sandoval, et al.
Genes and Immunity (2024) Vol. 25, Iss. 2, pp. 158-167
Closed Access | Times Cited: 2
Detection and comparison of SARS-CoV-2 antibody produced in naturally infected patients and vaccinated individuals in Addis Ababa, Ethiopia: multicenter cross-sectional study
Chala Bashea, Addisu Gize, Tadesse Lejisa, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Chala Bashea, Addisu Gize, Tadesse Lejisa, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011772-e1011772
Open Access | Times Cited: 4
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011772-e1011772
Open Access | Times Cited: 4
Durability of ChAdOx1 nCoV-19 (Covishield®) Vaccine Induced Antibody Response in Health Care Workers
Alka Verma, Amit Goel, Harshita Katiyar, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 84-84
Open Access | Times Cited: 5
Alka Verma, Amit Goel, Harshita Katiyar, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 84-84
Open Access | Times Cited: 5
Tracking B Cell Memory to SARS-CoV-2 Using Rare Cell Analysis System
Dong-Yan Tsai, Chun‐Hung Wang, Perry G. Schiro, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 735-735
Open Access | Times Cited: 1
Dong-Yan Tsai, Chun‐Hung Wang, Perry G. Schiro, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 735-735
Open Access | Times Cited: 1
Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand
Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, et al.
Vaccine X (2023) Vol. 14, pp. 100305-100305
Open Access | Times Cited: 1
Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, et al.
Vaccine X (2023) Vol. 14, pp. 100305-100305
Open Access | Times Cited: 1
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia
Yared Merid, Wondwosen Tekleselasie, Emnet Tesfaye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Yared Merid, Wondwosen Tekleselasie, Emnet Tesfaye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
